Why perform this test?
- To identify genetic predisposition to melanoma.
- To assess clinical risks for first-degree relatives.
- To establish personalized screening and prevention plans.
A precision genetic test identifying hereditary mutations linked to cutaneous melanoma. Ideal for families with a history of skin cancer to enable early detection and personalized preventive care strategies.
Scientific name: Melanoma Genetic Risk Assessment (CDKN2A/CDK4)
An advanced laboratory test screening for CDKN2A and CDK4 mutations associated with hereditary melanoma. It assesses genetic predisposition, helping clinicians develop personalized surveillance and preventive monitoring plans.